Metabolomics in pharmaceutical research and development: Metabolites, mechanisms and pathways

Current Opinion in Drug Discovery and Development

Volumn 12, Issue 1, 2009, Pages 40-52

  Xu, E Y ^a   Schaefer, W H ^a   Xu, Q ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Biochemical mechanisms; Identification; Metabolic profiling; Metabolomics; Metabonomics; NMR; Pathway analysis; Quantification; Systems biology

Indexed keywords

ALGORITHM; CHEMOMETRICS; DRUG MONITORING; DRUG RESEARCH; GENOTYPE PHENOTYPE CORRELATION; METABOLITE; METABOLOMICS; PROTEOMICS; QUANTITATIVE TRAIT LOCUS; REVIEW;

ANIMALS; DATABASES, FACTUAL; DRUG INDUSTRY; HUMANS; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PHARMACEUTICAL PREPARATIONS;

EID: 58449117420     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (108)

1. Nicholson JK, Lindon JC, Holmes E: 'Metabonomics': Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica (1999) 29(11):1181-1189.
2. Horning EC, Horning MG: Metabolic profiles: Gas-phase methods for analysis of metabolites. Clin Chem (1971) 17(8):802-809.
3. Pauling L, Robinson AB, Teranishi R, Cary P: Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci USA (1971) 68(10):2374-2376.
4. Nicholson JK, Connelly J, Lindon JC, Holmes E: Metabonomics: A platform for studying drug toxicity and gene function. Nat Rev Drug Discov (2002) 1(2):153-161.
5. Robertson DG: Metabonomics in toxicology: A review. Toxicol Sci (2005) 85(2):809-822.
6. Clarke CJ, Haselden JN: Metabolic profiling as a tool for understanding mechanisms of toxicity. Toxicol Pathol (2008) 36(1):140-147.
7. Robertson D, Reily MD, Cantor GH: Metabonomics in preclinical pharmaceutical discovery and development. In: The Handbook of Metabonomics and Metabolomics. Holmes E (Ed), Elsevier, Amsterdam, The Netherlands (2007):241-277.
8. 1H NMR-based metabolomic analysis of liver, serum, and brain following ethanol administration in rats. Chem Res Toxicol (2008) 21(2):408-420.
9. Dieterle F, Schlotterbeck G, Ross A, Niederhauser U, Senn H: Application of metabonomics in a compound ranking study in early drug development revealing drug-induced excretion of choline into urine. Chem Res Toxicol (2006) 19(9):1175-1181.
10. Viant MR: Environmental metabolomics using 1H-NMR spectroscopy. In: Methods in Molecular Biology. Environmental Genomics. Martin CC (Ed), Humana Press, Totowa, NJ, USA (2007) 410:137-150.
11. Miller MG: Environmental metabolomics: A SWOT analysis (strengths, weaknesses, opportunities, and threats). J Proteome Res (2007) 6(2):540-545.
12. Griffin JL, Shore RF: Applications of metabonomics within environmental toxicology. In: The Handbook of Metabonomics and Metabolomics. Holmes E (Ed), Elsevier, Amsterdam, The Netherlands (2007):517-532.
13. Holmes E, Loo RL, Stamler J, Bictash M, Yap IK, Chan Q, Ebbels T, De Iorio M, Brown IJ, Veselkov KA, Daviglus ML et al: Human metabolic phenotype diversity and its association with diet and blood pressure. Nature (2008) 453(7193):396-400.
14. Griffin JL, Vidal-Puig A: Current challenges in metabolomics for diabetes research: A vital functional genomic tool or just a ploy for gaining funding? Physiol Genomics (2008) 34(1):1-5.
15. Griffith HR, den Hollander JA, Okonkwo OC, O'Brien T, Watts RL, Marson DC: Brain N-acetylaspartate is reduced in Parkinson disease with dementia. Alzheimer Dis Assoc Disord (2008) 22(1):54-60.
16. 1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Mol Syst Biol (2008) 4:167.
17. Assfalg M, Bertini I, Colangiuli D, Luchinat C, Schafer H, Schutz B, Spraul M: Evidence of different metabolic phenotypes in humans. Proc Natl Acad Sci USA (2008) 105(5):1420-1424.
18. Raftery D, Gowda GA: An approaching new wave of multicomponent biomarker diagnostics? J Urol (2008) 179(6):2089-2090.
19. Clayton TA, Lindon JC, Cloarec O, Antti H, Charuel C, Hanton G, Provost JP, Le Net JL, Baker D, Walley RJ, Everett JR et al: Pharmaco- metabonomic phenotyping and personalized drug treatment. Nature (2006) 440(7087):1073-1077.
20. Kaddurah-Daouk R, McEvoy J, Baillie RA, Lee D, Yao JK, Doraiswamy PM, Krishnan KR: Metabolomic mapping of atypical antipsychotic effects in schizophrenia. Mol Psychiatry (2007) 12(10):934-945.
21. van Doorn M, Vogels J, Tas A, van Hoogdalem EJ, Burggraaf J, Cohen A, van der Greef J: Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in type 2 diabetes mellitus patients and healthy volunteers. Br J Clin Pharmacol (2007) 63(5):562-574.
22. Fiehn O: Metabolomics - the link between genotypes and phenotypes. Plant Mol Biol (2002) 48(1-2):155-171.
23. Sanchez DH, Siahpoosh MR, Roessner U, Udvardi M, Kopka J: Plant metabolomics reveals conserved and divergent metabolic responses to salinity. Physiol Plant (2008) 132(2):209-219.
24. Dixon RA, Gang DR, Charlton AJ, Fiehn O, Kuiper HA, Reynolds TL, Tjeerdema RS, Jeffery EH, German JB, Ridley WP, Seiber JN: Applications of metabolomics in agriculture. J Agric Food Chem (2006) 54(24):8984-8994.
25. Rabinowitz JD: Cellular metabolomics of Escherichia coli. Expert Rev Proteomics (2007) 4(2):187-198.
26. Ni Q, Reid KR, Burant CF, Kennedy RT: Capillary LC-MS for high sensitivity metabolomic analysis of single islets of Langerhans. Anal Chem (2008) 80(10):3539-3546.
27. Winder CL, Dunn WB, Schuler S, Broadhurst D, Jarvis R, Stephens GM, Goodacre R: Global metabolic profiling of Escherichia coli cultures: An evaluation of methods for quenching and extraction of intracellular metabolites. Anal Chem (2008) 80(8):2939-2948. • An informative paper comparing various quenching and extraction methods for intracellular metabolite profiling.
28. German JB, Roberts MA, Watkins SM: Personal metabolomics as a next generation nutritional assessment. J Nutr (2003) 133(12):4260- 4266.
29. Rezzi S, Ramadan Z, Fay LB, Kochhar S: Nutritional metabonomics: Applications and perspectives. J Proteome Res (2007) 6(2):513-525.
30. Rezzi S, Ramadan Z, Martin FP, Fay LB, van Bladeren P, Lindon JC, Nicholson JK, Kochhar S: Human metabolic phenotypes link directly to specific dietary preferences in healthy individuals. J Proteome Res (2007) 6(11):4469-4477.
31. Walsh MC, Brennan L, Malthouse JP, Roche HM, Gibney MJ: Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans. Am J Clin Nutr (2006) 84(3):531-539.
32. Gibney MJ, Walsh M, Brennan L, Roche HM, German B, van Ommen B: Metabolomics in human nutrition: Opportunities and challenges. Am J Clin Nutr (2005) 82(3):497-503.
33. Lu W, Bennett BD, Rabinowitz JD: Analytical strategies for LC-MS-based targeted metabolomics. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 871(2):236-242. •• Summary of the requirements for quantitative metabolomics using LC-MS. Suggestions for sample preparation, settings of chromatography and ionization, and selection of quantitative analysis using multiple reaction monitoring and high-resolution MS measurements.
34. Wilson ID, Plumb R, Granger J, Major H, Williams R, Lenz EM: HPLC-MS-based methods for the study of metabonomics. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 817(1):67-76.
35. Want EJ, Nordstrom A, Morita H, Siuzdak G: From exogenous to endogenous: The inevitable imprint of mass spectrometry in metabolomics. J Proteome Res (2007) 6(2):459-468.
36. Bennett BD, Yuan J, Kimball EH, Rabinowitz JD: Absolute quantitation of intracellular metabolite concentrations by an isotope ratio-based approach. Nat Protoc (2008) 3(8):1299-1311.
37. Dumas ME, Maibaum EC, Teague C, Ueshima H, Zhou B, Lindon JC, Nicholson JK, Stamler J, Elliott P, Chan Q, Holmes E: Assessment of analytical reproducibility of 1H NMR spectroscopy based metabonomics for large-scale epidemiological research: The INTERMAP Study. Anal Chem (2006) 78(7):2199-2208.
38. Nicholson JK, Holmes E, Wilson ID: Gut microorganisms, mammalian metabolism and personalized health care. Nat Rev Microbiol (2005) 3(5):431-438.
39. Bertram HC, Hoppe C, Petersen BO, Duus JØ, Mølgaard C, Michaelsen KF: An NMR-based metabonomic investigation on effects of milk and meat protein diets given to 8-year-old boys. Br J Nutr (2007) 97(4):758-763.
40. Stella C, Beckwith-Hall B, Cloarec O, Holmes E, Lindon JC, Powell J, van der Ouderaa F, Bingham S, Cross AJ, Nicholson JK: Susceptibility of human metabolic phenotypes to dietary modulation. J Proteome Res (2006) 5(10):2780-2788.
41. Gidley MJ: Naturally functional foods - challenges and opportunities. Asia Pac J Clin Nutr (2004) 13 (Suppl):S31.
42. Rücker G, Bohn G, Fell AF: [Identification and quantitative determination of ureides, methaqualone and barbiturates in autopsy material by NMR-spectroscopy]. Arch Toxikol (1971) 27(2):168-172.
43. Shoolery JN, Smithson LH: The use of a high resolution NMR spectrometer controlled by a dedicated computer for quantitative analytical chemistry. J Am Oil Chem Soc (1970) 47(5):153-157.
44. Xu Q, Abeygunawardana C, Ng AS, Sturgess AW, Harmon BJ, Hennessey JP Jr: Characterization and quantification of C-polysaccharide in Streptococcus pneumoniae capsular polysaccharide preparations. Anal Biochem (2005) 336(2):262-272.
45. Malz F, Jancke H: Validation of quantitative NMR. J Pharm Biomed Anal (2005) 38(5):813-823.
46. Nicholson JK, Higham DP, Timbrell JA, Sadler PJ: Quantitative high resolution 1H NMR urinalysis studies on the biochemical effects of cadmium in the rat. Mol Pharmacol (1989) 36(3):398-404.
47. Coen M, Hong YS, Clayton TA, Rohde CM, Pearce JT, Reily MD, Robertson DG, Holmes E, Lindon JC, Nicholson JK: The mechanism of galactosamine toxicity revisited; a metabonomic study. J Proteome Res (2007) 6(7):2711-2719.
48. Lewis GD, Asnani A, Gerszten RE: Application of metabolomics to cardiovascular biomarker and pathway discovery. J Am Coll Cardiol (2008) 52(2):117-123. • An insightful review discussing the limitations of chemometrics approaches to biological understanding of metabolomics data.
49. 1H NMR data sets. Anal Chem (2005) 77(5):1282-1289.
50. Crockford DJ, Holmes E, Lindon JC, Plumb RS, Zirah S, Bruce SJ, Rainville P, Stumpf CL, Nicholson JK: Statistical heterospectroscopy, an approach to the integrated analysis of NMR and UPLC-MS data sets: Application in metabonomic toxicology studies. Anal Chem (2006) 78(2):363-371.
51. Dieterle F, Ross A, Schlotterbeck G, Senn H: Metabolite projection analysis for fast identification of metabolites in metabonomics. Application in an amiodarone study. Anal Chem (2006) 78(11):3551-3561.
52. Wishart DS: Quantitative metabolomics using NMR. Trends Anal Chem (2008) 27(3):228-237. • An informative overview on the history and practical settings of quantitative NMR metabolomics.
53. Serkova NJ, Van Rheen Z, Tobias M, Pitzer JE, Wilkinson JE, Stringer KA: Utility of magnetic resonance imaging and nuclear magnetic resonance-based metabolomics for quantification of inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol (2008) 295(1):L152-L161.
54. Leibfritz D, Dreher W, Willker W: In vivo NMR applications of metabonomics. In: The Handbook of Metabonomics and Metabolomics. Holmes E (Ed), Elsevier, Amsterdam, The Netherlands (2007):489-516.
55. Shulman RG, Rothman DL (Ed): Metabolomics by In Vivo NMR. John Wiley & Sons Ltd, Chichester, UK (2005).
56. 1H NMR spectroscopy. J Magn Resonance B (1994) 104(1):1-10.
57. 1H NMR metabolomics data. Anal Chem (2006) 78(13):4430-4442.
58. Xu Q, Sachs JR, Wang TC, Schaefer WH: Quantification and identification of components in solution mixtures from 1D proton NMR spectra using singular value decomposition. Anal Chem (2006) 78(20):7175-7185. •• Provides a simple but robust mathematical solution to solving linearly additive NMR spectra by using reference component spectra encoded with quantitative properties.
59. Lewis IA, Schommer SC, Hodis B, Robb KA, Tonelli M, Westler WM, Sussman MR, Markley JL: Method for determining molar concentrations of metabolites in complex solutions from two-dimensional 1H-13C NMR spectra. Anal Chem (2007) 79(24):9385-9390.
60. Robosky LC, Wade K, Woolson D, Baker JD, Manning ML, Gage DA, Reily MD: Quantitative evaluation of sebum lipid components with nuclear magnetic resonance. J Lipid Res (2008) 49(3):686-692.
61. Provencher SW: Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med (1993) 30(6):672-679.
62. Provencher SW: Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed (2001) 14(4):260-264.
63. Gipson GT, Tatsuoka KS, Sweatman BC, Connor SC: Weighted least-squares deconvolution method for discovery of group differences between complex biofluid 1H NMR spectra. J Magn Resonance (2006) 183(2):269- 277.
64. 1H NMR data. Anal Bioanal Chem (2007) 389(3):875-885.
65. Nielsen N-PV, Carstensen JM, Smedsgaard J: Aligning of single and multiple wavelength chromatographic profiles for chemometric data analysis using correlation optimized warping. J Chromatogr A (1998) 805(1-2):17-35.
66. Pravdova V, Walczak B, Massart DL: A comparison of two algorithms for warping of analytical signals. Anal Chim Acta (2002) 456(1):77-92.
67. van Nederkassel AM, Daszykowski M, Eilers PH, Heyden YV: A comparison of three algorithms for chromatograms alignment. J Chromatogr A (2006) 1118(2):199-210.
68. Eilers PH: Parametric time warping. Anal Chem (2004) 76(2):404-411.
69. Wu W, Daszykowski M, Walczak B, Sweatman BC, Connor SC, Haselden JN, Crowther DJ, Gill RW, Lutz MW: Peak alignment of urine NMR spectra using fuzzy warping. J Chem Inf Model (2006) 46(2):863-875.
70. Otvos JD, Jeyarajah EJ, Bennett DW: Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy. Clin Chem (1991) 37(3):377-386.
71. 1H NMR spectra of human blood plasma. Magn Reson Med (1991) 21(2):222-232.
72. 1H NMR metabonomics as a prognostic and diagnostic tool. Expert Rev Mol Diagnostics (2007) 7(6):761-773.
73. Gomase VS, Changbhale SS, Patil SA, Kale KV: Metabolomics. Curr Drug Metab (2008) 9(1):89-98.
74. Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, Cheng D, Jewell K, Arndt D, Sawhney S, Fung C et al: HMDB: The Human Metabolome Database. Nucleic Acids Res (2007) 35:D521-D526. • HMDB is a high-quality metabolite database to facilitate both NMR- and MS-based quantitative metabolomics.
75. Cui Q, Lewis IA, Hegeman AD, Anderson ME, Li J, Schulte CF, Westler WM, Eghbalnia HR, Sussman MR, Markley JL: Metabolite identification via the Madison Metabolomics Consortium Database. Nat Biotechnol (2008) 26(2):162-164.
76. Smith CA, O'Maille G, Want EJ, Qin C, Trauger SA, Brandon TR, Custodio DE, Abagyan R, Siuzdak G: METLIN: A metabolite mass spectral database. Ther Drug Monit (2005) 27(6):747-751.
77. Benton HP, Wong DM, Trauger SA, Siuzdak G: XCMS2: Processing tandem mass spectrometry data for metabolite identification and structural characterization. Anal Chem (2008) 80(16):6382-6389.
78. Wishart DS, Lewis MJ, Morrissey JA, Flegel MD, Jeroncic K, Xiong Y, Cheng D, Eisner R, Gautam B, Tzur D, Sawhney S et al: The human cerebrospinal fluid metabolome. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 871(2):164-173. • Illustrates cerebrospinal fluid metabolite profiling as an excellent example of integrated metabolite-based quantitative metabolomics through literature text mining, identification and quantification by NMR, GC-MS, and LC-FTMS (Fourier transform MS).
79. Reily MD, Robosky LC, Manning ML, Butler A, Baker JD, Winters RT: DFTMP, an NMR reagent for assessing the near-neutral pH of biological samples. J Am Chem Soc (2006) 128(38):12360-12361.
80. Waters MD, Fostel JM: Toxicogenomics and systems toxicology: Aims and prospects. Nat Rev Genet (2004) 5(12):936-948.
81. Lindon JC, Holmes E, Nicholson JK: Global systems biology through integration of "omics" results. In: The Handbook of Metabonomics and Metabolomics. Holmes E (Ed), Elsevier, Amsterdam, The Netherlands (2007):533-555.
82. Stoughton RB, Friend SH: How molecular profiling could revolutionize drug discovery. Nat Rev Drug Discov (2005) 4(4):345-350.
83. Chen C, Shah YM, Morimura K, Krausz KW, Miyazaki M, Richardson TA, Morgan ET, Ntambi JM, Idle JR, Gonzalez FJ: Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis. Cell Metab (2008) 7(2):135-147. • An elegant series of experiments and analyses demonstrating the generation and verification of hypotheses on unobserved protein and mRNA changes from observed metabolite changes.
84. Vangala S, Tonelli A: Biomarkers, metabonomics, and drug development: Can inborn errors of metabolism help in understanding drug toxicity? AAPS J (2007) 9(3):E284-E297.
85. Xu EY, Perlina A, Vu H, Troth SP, Brennan RJ, Aslamkhan AG, Xu Q: Integrated pathway analysis of rat urine metabolic profiles and kidney transcriptomic profiles to elucidate the systems toxicology of model nephrotoxicants. Chem Res Toxicol (2008) 21(8):1548-1561. •• One of the first reports to attempt the integration of quantitative metabolomics with transcriptomics at the level of data co-analysis. Knowledge-based pathway enrichment analysis and metabolite-transcript correlation analysis were combined to build detailed biological models.
86. Friedman N, Linial M, Nachman I, Pe'er D: Using Bayesian networks to analyze expression data. J Comput Biol (2000) 7(3-4):601-620.
87. Rockman MV, Kruglyak L: Genetics of global gene expression. Nat Rev Genet (2006) 7(11):862-872. • An excellent review on the application of eQTL to elucidate the genetic architecture of quantitative traits. Readers unfamiliar with quantitative genetics are referred to this article for concise definitions of relevant terminology.
88. Griffiths AJF, Wessler SR, Lewontin RC, Carroll SB: Quantitative Genetics. In: Introduction to Genetic Analysis, 9th Edition. WH Freeman & Co Ltd, New York, NY, USA (2008):639-678.
89. Brem RB, Yvert G, Clinton R, Kruglyak L: Genetic dissection of transcriptional regulation in budding yeast. Science (2002) 296(5568):752-755.
90. Hubner N, Wallace CA, Zimdahl H, Petretto E, Schulz H, Maciver F, Mueller M, Hummel O, Monti J, Zidek V, Musilova A et al: Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nat Genet (2005) 37(3):243-253.
91. Schadt EE, Monks SA, Drake TA, Lusis AJ, Che N, Colinayo V, Ruff TG, Milligan SB, Lamb JR, Cavet G, Linsley PS et al: Genetics of gene expression surveyed in maize, mouse and man. Nature (2003) 422(6929):297-302.
92. Giovannoni JJ: Breeding new life into plant metabolism. Nat Biotechnol (2006) 24(4):418-419.
93. Sonoda J, Pei L, Evans RM: Nuclear receptors: Decoding metabolic disease. FEBS Lett (2008) 582(1):2-9.
94. Schauer N, Semel Y, Roessner U, Gur A, Balbo I, Carrari F, Pleban T, Perez-Melis A, Bruedigam C, Kopka J, Willmitzer L et al: Comprehensive metabolic profiling and phenotyping of interspecific introgression lines for tomato improvement. Nat Biotechnol (2006) 24(4):447-454.
95. Keurentjes JJ, Fu J, de Vos CH, Lommen A, Hall RD, Bino RJ, van der Plas LH, Jansen RC, Vreugdenhil D, Koornneef M: The genetics of plant metabolism. Nat Genet (2006) 38(7):842-849.
96. Wentzell AM, Rowe HC, Hansen BG, Ticconi C, Halkier BA, Kliebenstein DJ: Linking metabolic QTLs with network and cis-eQTLs controlling biosynthetic pathways. PLoS Genet (2007) 3(9):1687-1701.
97. Dumas ME, Wilder SP, Bihoreau MT, Barton RH, Fearnside JF, Argoud K, D'Amato L, Wallis RH, Blancher C, Keun HC, Baunsgaard D et al: Direct quantitative trait locus mapping of mammalian metabolic phenotypes in diabetic and normoglycemic rat models. Nat Genet (2007) 39(5):666-672.
98. Ferrara CT, Wang P, Neto EC, Stevens RD, Bain JR, Wenner BR, Ilkayeva OR, Keller MP, Blasiole DA, Kendziorski C, Yandell BS et al: Genetic networks of liver metabolism revealed by integration of metabolic and transcriptional profiling. PLoS Genet (2008) 4(3):e1000034. • Describes a case study integrating mQTL and eQTL to build experimentally testable causal models of the regulation of mouse liver metabolism.
99. Chaibub Neto E, Ferrara CT, Attie AD, Yandell BS: Inferring causal phenotype networks from segregating populations. Genetics (2008) 179(2):1089-1100.
100. Efron B, Tibshirani R: On testing the significance of sets of genes. Ann Appl Stat (2007) 1(1):107-129. • The GSA package represents the state of the art in gene-based pathway enrichment analysis algorithms.
101. Kim SY, Volsky DJ: PAGE: Parametric analysis of gene set enrichment. BMC Bioinformatics (2005) 6:144.
102. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA (2005) 102(43):15545-15550.
103. Ganter B, Zidek N, Hewitt PR, Muller D, Vladimirova A: Pathway analysis tools and toxicogenomics reference databases for risk assessment. Pharmacogenomics (2008) 9(1):35-54.
104. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA et al: Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat Genet (2000) 25(1):25-29.
105. Harris MA, Clark J, Ireland A, Lomax J, Ashburner M, Foulger R, Eilbeck K, Lewis S, Marshall B, Mungall C, Richter J et al: The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res (2004) 32:D258-D261.
106. Soga T, Baran R, Suematsu M, Ueno Y, Ikeda S, Sakurakawa T, Kakazu Y, Ishikawa T, Robert M, Nishioka T, Tomita M: Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption. J Biol Chem (2006) 281(24):16768-16776. • An interesting application of visualization software tools to overlay differential metabolite profiles onto metabolic pathway maps for the discovery of a potential oxidative stress biomarker.
107. Munger J, Bajad SU, Coller HA, Shenk T, Rabinowitz JD: Dynamics of the cellular metabolome during human cytomegalovirus infection. PLoS Pathog (2006) 2(12):e132. •• An excellent study integrating targeted LC-MS/MS metabolite quantification with transcriptomic profiling and enzyme activity assays. Solid conclusions were drawn on how viral infection reprograms host cell metabolism.
108. Adourian A, Jennings E, Balasubramanian R, Hines WM, Damian D, Plasterer TN, Clish CB, Stroobant P, McBurney R, Verheij ER, Bobeldijk I et al: Correlation network analysis for data integration and biomarker selection. Mol Biosystems (2008) 4(3):249-259.